Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
PD1/PD-L1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Keytruda
(pembrolizumab) / Merck (MSD)
Opdivo
(nivolumab) / BMS
Tecentriq
(atezolizumab) / Roche
AiRuiKa
(camrelizumab) / HLB Bio Group
Imfinzi
(durvalumab) / AstraZeneca
Bavencio
(avelumab) / EMD Serono
Tevimbra
(tislelizumab-jsgr) / BeiGene
Tyvyt
(sintilimab) / Eli Lilly
Jemperli
(dostarlimab-gxly) / GSK
Loqtorzi
(toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Libtayo
(cemiplimab-rwlc) / Regeneron
Kaitanni
(cadonilimab) / Akesobio
Enweida
(envafolimab) / 3DMed, Tracon Pharma, Ascletis
Zynyz
(retifanlimab-dlwr) / Incyte
bintrafusp alfa
(M7824) / EMD Serono
spartalizumab
(PDR001) / Novartis
Anniko
(penpulimab) / Akesobio, Sino Biopharm
balstilimab
(AGEN2034) / Agenus
socazolimab
(STI-A1014) / Sorrento
Yutuo
(zimberelimab) / Arcus Biosci, Gilead
T3011
/ ImmVira Pharma
benmelstobart
(APL-502) / Apollomics
ezabenlimab
(BI 754091) / Boehringer Ingelheim
izuralimab
(XmAb23104) / Xencor
sasanlimab
(PF-06801591) / Pfizer
Aibining
(geptanolimab) / Apollomics
GI-101
/ GI Innovation
LAE005
/ Laekna Therap
NY-ESO-1 TCR-T cell therapy
/ Gilead
Puyouheng
(pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med
VG161
/ ViroGin Biotech
pidilizumab
(CT-011) / CureTech
pradusinstobart
(LVGN3616) / Lyvgen
volrustomig
(MEDI5752) / AstraZeneca
zeluvalimab
(AMG 404) / Amgen
